Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a ...

With over 40 years of experience in the medical device and biotech industries, Bichsel has led marketing teams through multiple product launches, acquisitions, and market expansions. Drawing from real ...

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

As Robert F. Kennedy Jr. settles into his role as President Donald Trump’s health secretary, one major promise he’s made is ...

Turn Biotechnologies acquires drug delivery tech from Harvard & Vesigen Therapeutics to expand mRNA aging therapies; CEO Anja ...

Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) ...

Dr. Waltzman's panel, titled "Ensuring Effective and Efficient Trials Through Clinical Operations” will be Monday, April 7 th from 4:05PM - 4:35PM ET.

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

Plus: JetBlue CEO eyes more growth in Boston; AG Andrea Campbell offers fiery words about Trump; Charles River chamber offers ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to ...

Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically ...